These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 9839152)

  • 21. Mortality in heroin users 3 years after naltrexone implant or methadone maintenance treatment.
    Tait RJ; Ngo HT; Hulse GK
    J Subst Abuse Treat; 2008 Sep; 35(2):116-24. PubMed ID: 17931824
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Methadone- and heroin-related deaths in Florida.
    Graham NA; Merlo LJ; Goldberger BA; Gold MS
    Am J Drug Alcohol Abuse; 2008; 34(3):347-53. PubMed ID: 18428077
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Methadone-related and heroin-related deaths among opiate users: methadone helps save lives.
    Mattick RP; Degenhardt L
    Addiction; 2003 Apr; 98(4):387-8. PubMed ID: 12653808
    [No Abstract]   [Full Text] [Related]  

  • 24. The effectiveness and safety of methadone maintenance.
    Ward J; Mattick RP; Hall W; Darke S
    Addiction; 1996 Nov; 91(11):1727-9. PubMed ID: 8972930
    [No Abstract]   [Full Text] [Related]  

  • 25. Deaths attributable to methadone vs buprenorphine in France.
    Auriacombe M; Franques P; Tignol J
    JAMA; 2001 Jan; 285(1):45. PubMed ID: 11150107
    [No Abstract]   [Full Text] [Related]  

  • 26. The impact on retention of expansion of an Australian public methadone program.
    Bammer G; Battisson L; Ward J; Wilson S
    Drug Alcohol Depend; 2000 Feb; 58(1-2):173-80. PubMed ID: 10669069
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A 25-year follow-up of patients admitted to methadone treatment for the first time: mortality and gender differences.
    Jimenez-Treviño L; Saiz PA; García-Portilla MP; Díaz-Mesa EM; Sánchez-Lasheras F; Burón P; Casares MJ; Marina P; Gutiérrez E; Bobes J
    Addict Behav; 2011 Dec; 36(12):1184-90. PubMed ID: 21835551
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efforts to reduce overdose deaths.
    Sherman SG; Han J; Welsh C; Chaulk P; Serio-Chapman C
    Am J Public Health; 2013 Aug; 103(8):e1-2. PubMed ID: 23763429
    [No Abstract]   [Full Text] [Related]  

  • 29. The effectiveness of outreach case management in re-enrolling discharged methadone patients.
    Coviello DM; Zanis DA; Wesnoski SA; Alterman AI
    Drug Alcohol Depend; 2006 Oct; 85(1):56-65. PubMed ID: 16675163
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exposure to methadone programs and heroin use.
    Condelli WS; Dunteman GH
    Am J Drug Alcohol Abuse; 1993; 19(1):65-78. PubMed ID: 8438832
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patterns of nonfatal heroin overdose over a 3-year period: findings from the Australian treatment outcome study.
    Darke S; Williamson A; Ross J; Mills KL; Havard A; Teesson M
    J Urban Health; 2007 Mar; 84(2):283-91. PubMed ID: 17265131
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Death rates in treated and untreated heroin addicts.
    Gampel J
    Acta Psychiatr Scand; 1997 Feb; 95(2):166. PubMed ID: 9065684
    [No Abstract]   [Full Text] [Related]  

  • 33. Mortality in heroin addiction: impact of methadone treatment.
    Grönbladh L; Ohlund LS; Gunne LM
    Acta Psychiatr Scand; 1990 Sep; 82(3):223-7. PubMed ID: 2248048
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mortality among HIV-infected intravenous drug addicts in Stockholm in relation to methadone treatment.
    Fugelstad A; Rajs J; Böttiger M; Gerhardsson de Verdier M
    Addiction; 1995 May; 90(5):711-6. PubMed ID: 7795507
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparing drug-related hospital morbidity following heroin dependence treatment with methadone maintenance or naltrexone implantation.
    Ngo HT; Tait RJ; Hulse GK
    Arch Gen Psychiatry; 2008 Apr; 65(4):457-65. PubMed ID: 18391134
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Opioid-related mortality and filled prescriptions for buprenorphine and methadone.
    Wikner BN; Öhman I; Seldén T; Druid H; Brandt L; Kieler H
    Drug Alcohol Rev; 2014 Sep; 33(5):491-8. PubMed ID: 24735085
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of time spent in treatment and dropout status on rates of convictions, cautions and imprisonment over 5 years in a primary care-led methadone maintenance service.
    Oliver P; Keen J; Rowse G; Ewins E; Griffiths L; Mathers N
    Addiction; 2010 Apr; 105(4):732-9. PubMed ID: 20403022
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Methadone maintenance treatment: the balance between life-saving treatment and fatal poisonings.
    Fugelstad A; Stenbacka M; Leifman A; Nylander M; Thiblin I
    Addiction; 2007 Mar; 102(3):406-12. PubMed ID: 17298648
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Psychosocial correlates of retention in methadone maintenance.
    Steer RA
    Int J Addict; 1980 Oct; 15(7):1003-9. PubMed ID: 7450944
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Investigation of Repeat Client Drop-Out and Re-Enrolment Cycles in Fourteen Methadone Maintenance Treatment Clinics in Guangdong, China.
    Zhang L; Zou X; Zhang D; Li X; Zhao P; Ling L
    PLoS One; 2015; 10(10):e0139942. PubMed ID: 26484772
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.